Long-acting reversible contraception (LARC) insertion among US users increased from 2008 to 2013, but remained less than 2% of the sterilization rate, a recent study found. The retrospective cohort study used the 2008-2013 National Inpatient Sample and examined associations between predictors and likelihood of LARC and sterilization and compared characteristics of LARC and sterilization users. Researchers found:
- 4,691,683 discharges were included, representing 22,667,204 delivery hospitalizations.
- LARC insertion increased from 1.86 (2008-2009) to 13.5 (2012-2013) per 10,000 deliveries but remained <2% of the sterilization rate.
- LARC use was highest among women with medical comorbidities, nonprivate payer, and at urban teaching hospitals.
- Sterilization was least likely among women aged ≤24 years and most likely with cesarean delivery.
Moniz MH, Chang T, Heisler M, et al. Inpatient postpartum long-acting reversible contraception and sterilization in the United States, 2008-2013. [Published online ahead of print May 5, 2017]. Obstet Gynecol. doi:10.1097/AOG.0000000000001970.
This Week's Must Reads
Must Reads in Contraception
Bleeding and Spotting with the LNG 13.5 mg IUS, Contraception; ePub 2019 Mar 1; Shimoni, et al
Contraception and Chronic Opioid Prescriptions, Contraception; ePub 2019 Feb 11; Ray-Griffith, et al
Hormonal Contraception & Coexisting Medical Conditions, Obstet Gynecol; ePub 2019 Feb; Allen, et al
Contraceptive Switching & Discontinuation, Am J Obstet Gynecol; ePub 2018 Dec 18; Simmons, et al
Efficacy of a Levonorgestrel 52-mg IU System, Obstet Gynecol; ePub 2018 Dec 4; Teal, et al